KC allergist raises $200K to launch exposure-building immunity droplets for infants

A Kansas City physician-turned-founder has secured $200,000 in pre-launch funding to scale a solution that boosts healthy immune development in infants through early childhood with consistent exposure to food proteins.

Product imagery from the Amuse droplet-based allergy prevention solution; courtesy photo

The new approach to wellness is already attracting national attention and local support for Amuse, said Dr. Brynn Everist, a board-certified allergist and founder of Prairie Allergy in Prairie Village, Kansas.

“For years, I’ve cared for families navigating food allergies after they’ve already developed,” she said. “Amuse came from asking a different question: what if we could support the immune system earlier, in a way that feels simple and natural for families?”

Pre-launch financial backing included investors in Kansas City and across the country, Everist said, calling it an early signal of confidence in both the product and its mission. Polsinelli PC served as counsel.

Amuse offers a daily droplet designed to introduce small amounts of common food proteins in a format that integrates easily into an infant’s routine. The concept reflects a growing shift in how clinicians and parents think about early nutrition and immune development, Everist said.

The name itself is a nod to amuse-bouche — a small, thoughtful introduction that prepares for what’s to come — mirroring the product’s role in early, gentle exposure, she explained.

Dr. Brynn Everist, Amuse Prairie Allergy; courtesy photo

Everist credits her clinical experience as foundational to the company’s creation.

“The families I care for have shaped this from the beginning,” she said. “Their questions, their experiences — that’s what led to Amuse.”

Following a soft launch, Amuse has begun building a base of early customers, Everist said, with strong interest from parents seeking proactive, approachable ways to support their child’s health.

A launch celebration is planned for 5:30 p.m. April 30 at the Carriage Club in Kansas City, bringing together founders, physicians, investors, and families.

Click here for more details on the event or to RSVP.

“We’re building this in Kansas City on purpose,” Everist said. “The startup community here is collaborative, generous, and genuinely excited to see new ideas succeed. That support has been a huge part of getting Amuse off the ground.”

As momentum builds, Everist sees Amuse as part of a broader movement — one that blends clinical insight, consumer accessibility, and early support for immune health in a way that hasn’t traditionally existed in this space, she said.